Hunting Hill Global Capital’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Hunting Hill Global Capital’s Portfolio KDNY Stock Details KDNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-7,433	Closed	-$286K	–	142
2023 Q2	$286K	Buy	+7,433	New	+$191K	0.09%	80

Hunting Hill Global Capital's KDNY Position: Q3 2023 in Review

Hunting Hill Global Capital sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2023, closing a stake of 7,433 shares — an estimated $286K sold.

Hunting Hill Global Capital first reported a position in KDNY in Q2 2023 and held it in 1 quarter. The position peaked at $286K in Q2 2023. 2 funds tracked by Wall St. Rank hold KDNY as of Q3 2023.

Hunting Hill Global Capital reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Hunting Hill Global Capital sold 7,433 Chinook Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $286K.
Hunting Hill Global Capital first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
Hunting Hill Global Capital's Chinook Therapeutics, Inc. Common Stock position peaked at $286K in Q2 2023.
2 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Hunting Hill Global Capital's 13F filing for Q3 2023, filed 14 Nov 2023.